Fund Holdings — 5AM Venture Management, LLC

Total Portfolio Value:
$484.00M
Total Bought:
$61.24M
Total Sold:
$65.97M
Net Transaction:
-$4.73M
Notable People:
Anna Cosslett Yaeger
Securities
▲▼
SharesValue
Q2 2024
▲▼
Q3 2024
▲▼
Change
▲▼
Q2 2024
▲▼
Q3 2024
▲▼
Weight (%)
▲▼
Change
▲▼
Entrada Therapeutics, Inc.(TRDA)4,408,3794,408,3790$62.82M$70.45M14.55%+$7.63M
Enliven Therapeutics Inc2,610,8751,752,174-858,701$61.02M$44.75M9.25%-$16.27M
Skye Bioscience, Inc.(SKYE)10,179,5059,913,168-266,337$81.54M$38.76M8.01%-$42.78M
Artiva Biotherapeutics, Inc.(ARTV)02,353,304+2,353,304$0$36.36M7.51%+$36.36M
Dianthus Therapeutics, Inc.(DNTH)1,232,9651,231,619-1,346$31.91M$33.72M6.97%+$1.81M
Biohaven Ltd.(BHVN)469,972478,972+9,000$16.31M$23.93M4.95%+$7.62M
Tyra Biosciences, Inc.(TYRA)939,298939,2980$15.02M$22.08M4.56%+$7.06M
Centessa Pharmaceuticals PlcADS1,245,0001,285,000+40,000$11.24M$20.55M4.25%+$9.30M
Tectonic Therapeutic, Inc.(TECX)646,524646,5240$10.65M$19.59M4.05%+$8.94M
Praxis Precision Medicines, Inc.(PRAX)340,000340,0000$14.06M$19.56M4.04%+$5.50M
Celldex Therapeutics, Inc.(CLDX)497,270497,2700$18.40M$16.90M3.49%-$1.50M
Viridian Therapeutics, Inc.(VRDN)736,595736,5950$9.58M$16.76M3.46%+$7.17M
Viking Therapeutics, Inc.(VKTX)237,560237,5600$12.59M$15.04M3.11%+$2.45M
Pharvaris N V
COM
797,600797,6000$14.99M$14.77M3.05%-$223.3K
Erasca, Inc.(ERAS)5,405,4045,405,4040$12.76M$14.76M3.05%+$2.00M
MoonLake ImmunotherapeuticsCL A(MLTX)282,313282,3130$12.41M$14.23M2.94%+$1.82M
Anaptysbio Inc357,733357,7330$8.96M$11.98M2.48%+$3.02M
Silence Therapeutics plcADS(SLN)476,200476,2000$9.05M$8.66M1.79%-$390.5K
EyePoint, Inc.(EYPT)50,0001,050,000+1,000,000$435.0K$8.39M1.73%+$7.95M
Cogent Biosciences, Inc.(COGT)790,440561,854-228,586$6.66M$6.07M1.25%-$595.4K
Scpharmaceuticals Inc1,200,6471,200,6470$5.22M$5.47M1.13%+$252.1K
Vor Biopharma Inc.(VOR)6,361,7236,361,7230$6.36M$4.45M0.92%-$1.91M
Rallybio Corporation(RLYB)3,630,7243,630,7240$4.87M$4.25M0.88%-$617.2K
GH Research PLC(GHRS)572,665572,6650$6.68M$3.83M0.79%-$2.85M
Adverum Biotechnologies Inc541,666541,6660$3.72M$3.80M0.79%+$86.7K
Mersana Therapeutics Inc1,305,0001,305,0000$2.62M$2.47M0.51%-$156.6K
Zentalis Pharmaceuticals, Inc.(ZNTL)490,000490,0000$2.00M$1.80M0.37%-$200.9K
Cidara Therapeutics Inc56,72556,7250$677.3K$609.8K0.13%-$67.5K
Q32 Bio Inc.(QTTB)251,9940-251,994$4.52M$0—-$4.52M
Page 1 of 1
5AM Venture Management, LLC — 13F Holdings — Q3 2024 | TickerTrail